BackClover Health Investments Overview
Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Target Price

See Clover Health Investments's analyst price targets ($4.8) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.27

Average Target Price

$4.8212.9% upside

3 analysts in the last 4 months

High: $5.5 | Low: $4.2

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-21Canaccord Genuity$5.529% upsideOpen
2026-06-11UBSJonathan Yong$4.7511.4% upsideOpen
2026-06-04Canaccord GenuityRichard Close$4.21.5% downsideOpen
2025-10-21Leerink PartnersWhit Mayo$329.7% downsideOpen
2024-12-17Craig-HallumMatt Hewitt$640.7% upsideOpen
2024-08-06Canaccord GenuityRichard Close$2.541.4% downsideOpen
2022-11-16Citigroup$1.857.8% downsideOpen

Clover Health Investments (CLOV) FAQ

Clover Health Investments (CLOV) currently reports a target price of $4.8. Use the charts on this page to explore Clover Health Investments's target price history and peer comparisons.

Analysts' average 12-month price target for Clover Health Investments is $4.8, about 12.9% upside from the current share price of $4.27. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $4.8, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Clover Health Investments, and consider following CLOV for alerts when major investors trade the stock.

Clover Health Investments is classified in the Finance sector. On target price, it currently shows $4.8. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Finance are usually more informative than comparing CLOV with unrelated industries.